1. Description
Ovagen peptide is an ovarian tissue-specific biological regulatory peptide derived from the Cytogen biological regulatory peptide technology platform in Russia. It is an artificially synthesized short chain peptide that targets the gene expression and metabolic function of ovarian cells, restoring the physiological activity of ovarian tissue. It belongs to non hormonal ovarian function regulatory agents. This peptide is in the form of a white to off white freeze-dried powder, easily soluble in sterile injection water, physiological saline and other aqueous solvents. It has a small molecular weight and high bioavailability, and can directly act on ovarian granulosa cells and follicular cells without interfering with the hormone balance of the hypothalamic pituitary ovarian axis. There are no hormone like side effects such as estrogen and progesterone. It has excellent storage stability and can be stored for a long time under sealed and dark conditions at room temperature. After reconstitution, it needs to be prepared and used immediately. It is a professional peptide raw material in the field of female reproductive health and ovarian function maintenance.
2. Application
Ovagen peptides are mainly used in the fields of female reproductive health maintenance, intervention for ovarian dysfunction, and assisted reproductive medicine. They can also be used as biologically active ingredients for female anti-aging regulation. In clinical and health management settings, it is commonly used for individuals with ovarian dysfunction caused by natural aging or iatrogenic factors such as chemotherapy and surgery, to help improve ovarian reserve function; For patients with polycystic ovary syndrome (PCOS) accompanied by follicular dysplasia, it can be used as an auxiliary conditioning agent to promote normal follicular development and maturation; In assisted reproductive technologies such as in vitro fertilization, it can enhance the responsiveness of the ovaries to ovulation inducing drugs and increase the number of high-quality follicles; In addition, it can also be used for the regulation of perimenopausal syndrome in women, relieving discomfort symptoms caused by ovarian function decline such as hot flashes, insomnia, and emotional fluctuations. It is also suitable for healthy women with ovarian maintenance needs as a preventive reproductive health maintenance material.
3. Main Efficacy
The core efficacy of Ovagen peptide revolves around regulating ovarian function and maintaining reproductive health, achieving physiological function repair and enhancement through multi-target action on ovarian tissue. Firstly, it can activate the proliferation and differentiation of ovarian granulosa cells, promote the expression of follicle stimulating hormone (FSH) receptors, enhance the sensitivity of the ovary to gonadotropins, thereby improving follicular development disorders, enhancing ovarian reserve capacity, and increasing the probability of producing high-quality eggs. Secondly, this peptide can inhibit the oxidative stress response of ovarian tissue, eliminate excess reactive oxygen species (ROS), reduce apoptosis of ovarian cells, protect the ovarian follicular pool from damage, and delay the physiological aging process of the ovary. At the same time, it can regulate the local cytokine network of the ovary, balance the secretion of anti-inflammatory and pro-inflammatory factors, improve the ovarian microenvironment, alleviate chronic inflammation of ovarian tissue, and have an auxiliary regulatory effect on inflammation related ovarian diseases such as polycystic ovary syndrome. In addition, Ovagen peptide can indirectly regulate female endocrine balance, improve menstrual disorders and amenorrhea caused by ovarian dysfunction, alleviate vascular and neurological symptoms during perimenopause, improve female reproductive health and quality of life, and avoid the risks of endometrial and breast hyperplasia that may arise from hormone replacement therapy.
